Prominent gallbladder enlargement: Kawasaki disease or other congenital or acquired gallbladder disease? A case report.
Liang ZhaoYimin HuaKaiyu ZhouPublished in: The Journal of international medical research (2021)
Kawasaki disease (KD) is a common systemic vasculitis in childhood that can result in damage to multiple body systems. However, prominent gallbladder (GB) enlargement in the acute stage is especially rare. A 5-year-old boy was admitted to the hospital with an 8-day history of a cervical mass, 7-day history of fever, and 5-day history of abdominal pain and rash. The child was diagnosed with KD. After treatment with high-dose intravenous immunoglobulin therapy (2 g/kg), all clinical manifestations were relieved except the abdominal pain. Enhanced computed tomography showed distinct enlargement of the GB, and a congenital choledochal cyst was strongly suspected. After high-dose glucocorticoid treatment, his obviously enlarged GB returned to normal size in the subacute phase. No abnormality was found during 2 years of follow-up. Prominent GB enlargement may emerge in the acute stage of KD. The enlarged GB can return to normal size within the subacute stage by standard treatment for KD. Proper diagnosis, thorough differential diagnosis, and active anti-inflammatory treatment of KD are crucial to avoid surgery.
Keyphrases
- high dose
- abdominal pain
- computed tomography
- liver failure
- low dose
- magnetic resonance imaging
- healthcare
- minimally invasive
- stem cell transplantation
- stem cells
- emergency department
- mental health
- pulmonary embolism
- intensive care unit
- coronary artery disease
- hepatitis b virus
- replacement therapy
- magnetic resonance
- young adults
- atrial fibrillation
- percutaneous coronary intervention
- early life
- pet ct
- dual energy